X-ray Absorption Near Edge Structure Spectroscopy to Resolve the in Vivo Chemistry of the Redox-Active Indazoliumtrans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019)
Open Access
- 31 January 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (3) , 1182-1196
Abstract
Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (1, KP1019) and its analogue sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (2, KP1339) are promising redox-active anticancer drug candidates that were investigated with X-ray absorption near edge structure spectroscopy. The analysis was based on the concept of the coordination charge and ruthenium model compounds representing possible coordinations and oxidation states in vivo. 1 was investigated in citrate saline buffer (pH 3.5) and in carbonate buffer (pH 7.4) at 37 °C for different time intervals. Interaction studies on 1 with glutathione in saline buffer and apo-transferrin in carbonate buffer were undertaken, and the coordination of 1 and 2 in tumor tissues was studied too. The most likely coordinations and oxidation states of the compound under the above mentioned conditions were assigned. Microprobe X-ray fluorescence of tumor thin sections showed the strong penetration of ruthenium into the tumor tissue, with the highest concentrations near blood vessels and in the edge regions of the tissue samples.Keywords
This publication has 89 references indexed in Scilit:
- Redox activation of metal-based prodrugs as a strategy for drug deliveryAdvanced Drug Delivery Reviews, 2012
- Anticancer Activity of Metal Complexes: Involvement of Redox ProcessesAntioxidants & Redox Signaling, 2011
- Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339JBIC Journal of Biological Inorganic Chemistry, 2010
- New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugsChemical Communications, 2010
- X-ray absorption spectroscopyPhotosynthesis Research, 2009
- Biological X-ray absorption spectroscopy and metalloproteomicsJournal of Synchrotron Radiation, 2009
- Assignment of pre-edge features in the Ru K-edge X-ray absorption spectra of organometallic ruthenium complexesInorganica Chimica Acta, 2008
- Development of Organometallic Ruthenium(II) Anticancer (RAPTA) DrugsChimia, 2007
- Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibitionChemico-Biological Interactions, 1995
- Determination of the Mo surface environment of Mo/TiO2 catalysts by EXAFS, XANES and PCAMicrochimica Acta, 1992